Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sandra Roche
Observed names:
Roche, Sandra,
S Roche,
S. Roche
Institutions:
Royal College of Surgeons in Ireland,
Beaumont Hospital,
Connaissance et Valorisation : Chimie des matériaux Environnement, Energie,
Université des Antilles
Observed institutions:
Royal College of Surgeons in Ireland,
Beaumont Hospital,
St. Vincent's University Hospital,
Dublin City University,
Synthesis and Solid State Pharmaceutical Centre,
Connaissance et Valorisation : Chimie des matériaux Environnement, Energie,
Université des Antilles
show all 7
ORCID:
0000-0002-4363-4607
Observed ORCID:
0000-0002-4363-4607
OpenAlex ID:
A5080905361
Resistance to Paclitaxel in a Cisplatin-Resistant Ovarian Cancer Cell Line Is Mediated by P-Glycoprotein
2012
·
Britta Stordal
, Marion Hamon
, et al.
·
PLoS ONE
·
94
PDF
Stable Aqueous Dispersions of Glycopeptide‐Grafted Selectably Functionalized Magnetic Nanoparticles
2013
·
Tushar Borase
, Tsedev Ninjbadgar
, et al.
·
Angewandte Chemie International Edition
·
87
Development of a high-performance liquid chromatographic–mass spectrometric method for the determination of cellular levels of the tyrosine kinase inhibitors lapatinib and dasatinib
2009
·
Sandra Roche
, Gillian McMahon
, et al.
·
Journal of Chromatography B
·
47
Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line organoid development
2020
·
Shannon R. Nelson
, Chenxi Zhang
, et al.
·
Scientific Reports
·
43
PDF
Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer
2020
·
Alexandra Canonici
, Alacoque L. Browne
, et al.
·
Therapeutic Advances in Medical Oncology
·
34
Dasatinib Attenuates Pressure Overload Induced Cardiac Fibrosis in a Murine Transverse Aortic Constriction Model
2015
·
Sundaravadivel Balasubramanian
, Dorea L. Pleasant
, et al.
·
PLoS ONE
·
34
PDF
Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells
2019
·
Patricia Gaule
, Nupur Mukherjee
, et al.
·
Cancers
·
31
PDF
A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts
2018
·
Orla Coleman
, Michael Henry
, et al.
·
Proteomes
·
30
PDF
DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models
2020
·
Michael C. Johnston
, Julie A. Nicoll
, et al.
·
Journal of Controlled Release
·
28
Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients
2020
·
Sandra Roche
, Fiona O’Neill
, et al.
·
International Journal of Molecular Sciences
·
23
PDF
Modulation of P-gp expression by lapatinib
2010
·
Gráinne Dunne
, Laura Breen
, et al.
·
Investigational New Drugs
·
23
Development, validation and application of a sensitive LC–MS/MS method for the quantification of thalidomide in human serum, cells and cell culture medium
2012
·
Sandra Roche
, Louise Sewell
, et al.
·
Journal of Chromatography B
·
13
Genomic Profiling and Functional Analysis of let-7c miRNA-mRNA Interactions Identify SOX13 to Be Involved in Invasion and Progression of Pancreatic Cancer
2020
·
Shannon R. Nelson
, Sandra Roche
, et al.
·
Journal of Oncology
·
12
PDF
Proteomic Analysis of Cell Lines and Primary Tumors in Pancreatic Cancer Identifies Proteins Expressed Only In Vitro and Only In Vivo
2020
·
Orla Coleman
, Michael Henry
, et al.
·
Pancreas
·
10
Lung Health Check pilot: Ireland’s flagship lung cancer screening trial
2025
·
David O Reilly
, Sandra Roche
, et al.
·
BMJ Open Respiratory Research
·
7
PDF
Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer
2023
·
Sandra Roche
, Patricia Gaule
, et al.
·
PLoS ONE
·
7
PDF
Neratinib plus dasatinib is highly synergistic in HER2-positive breast cancer in vitro and in vivo
2024
·
Neil T Conlon
, Sandra Roche
, et al.
·
Translational Oncology
·
6
Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These Tumors
2023
·
Fiona O’Neill
, Taylor-Jade Allen-Coyle
, et al.
·
Life
·
6
PDF
Pancreatic Cancer 3D Cell Line Organoids (CLOs) Maintain the Phenotypic Characteristics of Organoids and Accurately Reflect the Cellular Architecture and Heterogeneity In Vivo
2022
·
Sara Noorani
, Shannon R. Nelson
, et al.
·
Organoids
·
6
PDF
Stable Aqueous Dispersions of Glycopeptide‐Grafted Selectably Functionalized Magnetic Nanoparticles
2013
·
Tushar Borase
, Tsedev Ninjbadgar
, et al.
·
Angewandte Chemie
·
5
Development and application of novel analytical methods for molecularly targeted cancer therapeutics
2011
·
Sandra Roche
·
Dublin City University Open Access Institutional Repository (Dublin City University)
·
5
PDF
P2.04A.04 The Lung Health Check Pilot: Ireland's Flagship Lung Cancer Screening Trial
2024
·
D.E.O. Reilly
, S. Roche
, et al.
·
Journal of Thoracic Oncology
·
4
PDF
FOLFIRINOX Pharmacodynamic Interactions in 2D and 3D Pancreatic Cancer Cell Cultures
2022
·
Taylor J. Allen-Coyle
, Jin Niu
, et al.
·
The AAPS Journal
·
4
PDF
Identification of potential new treatment response markers and therapeutic targets using a Gaussian process-based method in lapatinib insensitive breast cancer models
2017
·
Tapesh Santra
, Sandra Roche
, et al.
·
PLoS ONE
·
4
PDF
Pre-clinical evaluation of the PP2A inhibitor LB-100 for the treatment of lapatinib resistant HER2-positive breast cancer.
2018
·
Neil Conlon
, Martina McDermott
, et al.
·
Journal of Clinical Oncology
·
3
Show more works
View as search
Works count:
38
Citation count:
572
H-index:
12
I10-index:
14
Year
Topic
Type